Kearns Evan 4
4 · Cogent Biosciences, Inc. · Filed May 5, 2021
Insider Transaction Report
Form 4
Kearns Evan
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-05-03+260,000→ 260,000 totalExercise: $8.93Exp: 2031-05-03→ Common Stock (260,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest over a four year period as follows: 1/4th of the option shall vest one year after the vesting start date; then 1/48th of the option shall vest monthly over the remaining three year period.